Breaking News Instant updates and real-time market news.

FIXX

Homology Medicines

$39.00 /

+16 (+1.00%)

16:26
11/09/20
11/09
16:26
11/09/20
16:26

Homology Medicines reports Q 3EPS (62c), consensus (80c)

Announced today a $60 million equity investment from Pfizer Inc. with the purchase of 5,000,000 shares of common stock at a price of $12.00 per share, which is expected to close on or about November 10, 2020. The investment includes a right of first refusal on future transactions for the Company's phenylketonuria (PKU) product candidates: HMI-102 gene therapy candidate for adults with PKU and HMI-103 gene editing candidate for pediatric patients with PKU. As announced on November 6, 2020, plans to progress the pheNIX gene therapy clinical trial for adults with PKU to the randomized, concurrently controlled dose expansion phase with two doses. The expansion phase has the potential to be converted to a registrational trial.."At the end of last week, we announced an important milestone for the PKU community and Homology with the positive data from the dose-escalation phase of our pheNIX PKU gene therapy clinical trial and plans to initiate the dose expansion phase by early 2021," stated Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines. Dr. Tzianabos added, "We also recently announced that we have expanded our CNS portfolio by unveiling a new gene therapy program for Hunter syndrome. Our in vivo approach with HMI-203 leverages the potential of AAVHSCs to target peripheral organs and central and peripheral nervous systems following an I.V. administration. We believe this advantage, coupled with our team's direct development and commercialization experience in Hunter syndrome, provides an opportunity to address the cognitive as well as systemic effects of this fatal disorder. HMI-203 has already been scaled up to 500 liters in our internal manufacturing facility, leveraging our plug and play system that is designed to enable rapid development across our gene therapy and gene editing programs."

FIXX Homology Medicines
$39.00 /

+16 (+1.00%)

11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
08/11/20 Oppenheimer
Homology Medicines price target lowered to $27 from $32 at Oppenheimer
08/11/20 Oppenheimer
Homology Medicines price target lowered to $27 from $32 at Oppenheimer
08/11/20 H.C. Wainwright
Homology Medicines price target lowered to $30 from $37 at H.C. Wainwright
08/11/20 H.C. Wainwright
Homology Medicines price target lowered to $30 from $37 at H.C. Wainwright
07/01/20 Baird
Homology Medicines elevated to Fresh Pick at Baird
07/01/20 Baird
Homology Medicines elevated to Fresh Pick at Baird

TODAY'S FREE FLY STORIES

Earnings
Titan Machinery raises FY21 adj. EPS view to $1.05 - $1.15 from 65c-85c  06:47
11/24/20
11/24
06:47
11/24/20
06:47
TITN

Titan Machinery

$18.95 /

+0.59 (+3.21%)

FY21 consensus 85c.

ShowHide Related Items >><<
TITN Titan Machinery
$18.95 /

+0.59 (+3.21%)

10/21/20 William Blair
Titan Machinery upgraded to Outperform from Market Perform at William Blair
03/27/20 Stephens
Titan Machinery price target lowered to $15 from $23 at Stephens
TITN Titan Machinery
$18.95 /

+0.59 (+3.21%)

Earnings
Titan Machinery reports Q3 adjusted EPS 58c, consensus 35c » 06:46
11/24/20
11/24
06:46
11/24/20
06:46
TITN

Titan Machinery

$34.00 /

+18 (+9.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TITN Titan Machinery
$34.00 /

+18 (+9.00%)

10/21/20 William Blair
Titan Machinery upgraded to Outperform from Market Perform at William Blair
03/27/20 Stephens
Titan Machinery price target lowered to $15 from $23 at Stephens
TITN Titan Machinery
$34.00 /

+18 (+9.00%)

Earnings
Burlington Stores reports Q3 non-GAAP EPS 29c, consensus 16c » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
BURL

Burlington Stores

$230.17 /

-2.76 (-1.18%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$230.17 /

-2.76 (-1.18%)

BURL Burlington Stores
$230.17 /

-2.76 (-1.18%)

11/12/20 Gordon Haskett
Burlington Stores upgraded to Buy from Accumulate at Gordon Haskett
11/12/20 Deutsche Bank
Burlington Stores price target raised to $246 from $221 at Deutsche Bank
11/12/20 Gordon Haskett
Burlington Stores upgraded to Buy from Accumulate at Gordon Haskett
10/28/20
Fly Intel: Top five analyst initiations
BURL Burlington Stores
$230.17 /

-2.76 (-1.18%)

BURL Burlington Stores
$230.17 /

-2.76 (-1.18%)

BURL Burlington Stores
$230.17 /

-2.76 (-1.18%)

Recommendations
Honeywell price target raised to $221 from $167 at Baird » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
HON

Honeywell

$204.72 /

+2.66 (+1.32%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HON Honeywell
$204.72 /

+2.66 (+1.32%)

HON Honeywell
$204.72 /

+2.66 (+1.32%)

11/18/20
Fly Intel: Top five analyst downgrades
11/18/20 Jefferies
Jefferies sees Honeywell at 'peak valuation,' downgrades to Hold
11/18/20 Jefferies
Honeywell downgraded to Hold from Buy at Jefferies
11/17/20 HSBC
Honeywell downgraded to Hold from Buy at HSBC
HON Honeywell
$204.72 /

+2.66 (+1.32%)

HON Honeywell
$204.72 /

+2.66 (+1.32%)

HON Honeywell
$204.72 /

+2.66 (+1.32%)

HON Honeywell
$204.72 /

+2.66 (+1.32%)

Upgrade
AerCap upgraded to Buy from Neutral at BofA » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
AER

AerCap

$40.41 /

+2.5 (+6.59%)

BofA analyst Ronald…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AER AerCap
$40.41 /

+2.5 (+6.59%)

AER AerCap
$40.41 /

+2.5 (+6.59%)

06:33 Today BofA
AerCap upgraded to Buy from Neutral at BofA
11/11/20 Barclays
AerCap price target raised to $42 from $39 at Barclays
10/02/20 Deutsche Bank
Deutsche Bank opens 'short-term Buy Catalyst Call' on AerCap
06/01/20
Fly Intel: Top five analyst downgrades
AER AerCap
$40.41 /

+2.5 (+6.59%)

  • 03
    Dec
AER AerCap
$40.41 /

+2.5 (+6.59%)

AER AerCap
$40.41 /

+2.5 (+6.59%)

Downgrade
ViacomCBS downgraded to Hold from Buy at Deutsche Bank » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
VIAC

ViacomCBS

$34.61 /

+0.6 (+1.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

10/15/20
Fly Intel: Top five analyst upgrades
10/15/20 Barclays
ViacomCBS upgraded to Overweight from Equal Weight at Barclays
10/09/20 Needham
ViacomCBS price target raised to $36 from $30 at Needham
10/01/20 Loop Capital
ViacomCBS initiated with a Hold at Loop Capital
VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

VIAC ViacomCBS
$34.61 /

+0.6 (+1.76%)

Upgrade
Richemont upgraded to Neutral from Underperform at Credit Suisse » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
CFRUY

Richemont

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFRUY Richemont
$0.00 /

+ (+0.00%)

CFRUY Richemont
$0.00 /

+ (+0.00%)

11/17/20 UBS
Richemont price target raised to CHF 73.30 from CHF 59.70 at UBS
11/11/20 Bernstein
Richemont downgraded to Market Perform from Outperform at Bernstein
11/11/20 BofA
Richemont upgraded to Buy from Underperform at BofA
11/09/20 RBC Capital
Richemont price target raised to CHF 79 from CHF 69 at RBC Capital
Earnings
Jacobs Engineering sees FY21 adj. EPS $5.20-$6.00, consensus $5.81 » 06:45
11/24/20
11/24
06:45
11/24/20
06:45
J

Jacobs Engineering

$104.65 /

+0.79 (+0.76%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

09/22/20 Bernstein
Jacobs initiated with an Outperform at Bernstein
07/01/20 Stifel
Jacobs secures 'key strategic, highly competitive' takeaway win, says Stifel
05/12/20 Argus
Jacobs price target lowered to $100 from $116 at Argus
05/11/20 DA Davidson
Jacobs price target lowered to $95 from $110 at DA Davidson
J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

Initiation
SQZ Biotechnologies initiated with a Buy at BofA » 06:43
11/24/20
11/24
06:43
11/24/20
06:43
SQZ

SQZ Biotechnologies

$27.48 /

-4.56 (-14.23%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$27.48 /

-4.56 (-14.23%)

SQZ SQZ Biotechnologies
$27.48 /

-4.56 (-14.23%)

06:02 Today BofA
SQZ Biotechnologies initiated with a Buy at BofA
05:52 Today BTIG
SQZ Biotechnologies initiated with a Buy at BTIG
  • 30
    Oct
Earnings
Jacobs Engineering reports Q4 adj. EPS $1.63, consensus $1.32 » 06:43
11/24/20
11/24
06:43
11/24/20
06:43
J

Jacobs Engineering

$104.65 /

+0.79 (+0.76%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

09/22/20 Bernstein
Jacobs initiated with an Outperform at Bernstein
07/01/20 Stifel
Jacobs secures 'key strategic, highly competitive' takeaway win, says Stifel
05/12/20 Argus
Jacobs price target lowered to $100 from $116 at Argus
05/11/20 DA Davidson
Jacobs price target lowered to $95 from $110 at DA Davidson
J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

J Jacobs Engineering
$104.65 /

+0.79 (+0.76%)

Initiation
Cue Biopharma initiated with a Buy at Berenberg » 06:42
11/24/20
11/24
06:42
11/24/20
06:42
CUE

Cue Biopharma

$12.01 /

-0.22 (-1.80%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CUE Cue Biopharma
$12.01 /

-0.22 (-1.80%)

CUE Cue Biopharma
$12.01 /

-0.22 (-1.80%)

05/20/20 Oppenheimer
Cue Biopharma price target raised to $32 from $27 at Oppenheimer
05/20/20 BTIG
Cue Biopharma price target raised to $33 from $26 at BTIG
04/21/20 Stifel
Cue Biopharma price target raised to $25 from $21 at Stifel
04/09/20
Fly Intel: Top five analyst initiations
CUE Cue Biopharma
$12.01 /

-0.22 (-1.80%)

Initiation
Black Diamond Therapeutics initiated with a Buy at Berenberg » 06:40
11/24/20
11/24
06:40
11/24/20
06:40
BDTX

Black Diamond Therapeutics

$33.63 /

+0.24 (+0.72%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$33.63 /

+0.24 (+0.72%)

BDTX Black Diamond Therapeutics
$33.63 /

+0.24 (+0.72%)

06:38 Today Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/04/20 H.C. Wainwright
Black Diamond Therapeutics initiated with a Buy at H.C. Wainwright
02/24/20 Cowen
Black Diamond Therapeutics initiated with an Outperform at Cowen
BDTX Black Diamond Therapeutics
$33.63 /

+0.24 (+0.72%)

  • 30
    Jan
Recommendations
Urban Outfitters price target raised to $30 from $22 at RBC Capital » 06:39
11/24/20
11/24
06:39
11/24/20
06:39
URBN

Urban Outfitters

$31.66 /

+1.335 (+4.40%)

RBC Capital analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

06:36 Today Barclays
Urban Outfitters price target raised to $37 from $26 at Barclays
11/23/20 Morgan Stanley
Urban Outfitters price target raised to $30 from $28 at Morgan Stanley
11/23/20 JPMorgan
Urban Outfitters price target raised to $27 from $19 at JPMorgan
11/18/20 B. Riley Securities
Urban Outfitters price target raised to $25 from $20 at B. Riley Securities
URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

Earnings
Tiffany sees 'low-double-digit percentage increase in operating earnings' in Q4 » 06:39
11/24/20
11/24
06:39
11/24/20
06:39
TIF

Tiffany

$131.50 /

+0.07 (+0.05%)

The company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

10/28/20
LVMH, Tiffany near agreement on $131.50 per share price, WSJ reports
10/16/20 William Blair
Tiffany results strengthen legal standing against LVMH, says William Blair
09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

Recommendations
Extended Stay America price target raised to $17 from $16 at Barclays » 06:38
11/24/20
11/24
06:38
11/24/20
06:38
STAY

Extended Stay America

$13.20 /

+0.49 (+3.86%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

09/30/20 JPMorgan
Extended Stay America upgraded to Overweight with $15 target at JPMorgan
09/30/20 JPMorgan
Extended Stay America upgraded to Overweight from Neutral at JPMorgan
09/29/20 BofA
BofA increasing exposure to Lodging, upgrades Park Hotels, Pebblebrook, Sunstone
09/29/20 BofA
Extended Stay America upgraded to Buy from Neutral at BofA
STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

STAY Extended Stay America
$13.20 /

+0.49 (+3.86%)

Initiation
Arcus Biosciences initiated with a Buy at Berenberg » 06:37
11/24/20
11/24
06:37
11/24/20
06:37
RCUS

Arcus Biosciences

$25.77 /

+1.365 (+5.59%)

, GILD

Gilead

$59.88 /

-0.22 (-0.37%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCUS Arcus Biosciences
$25.77 /

+1.365 (+5.59%)

GILD Gilead
$59.88 /

-0.22 (-0.37%)

RCUS Arcus Biosciences
$25.77 /

+1.365 (+5.59%)

11/23/20 Evercore ISI
Arcus Biosciences initiated with an Outperform at Evercore ISI
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
06/03/20 SVB Leerink
Gilead upgraded to Outperform at SVB Leerink on remdesivir sales, Arcus deal
GILD Gilead
$59.88 /

-0.22 (-0.37%)

11/20/20 Raymond James
Use of Gilead's remdesivir likely to skew to U.S. into Q1, says Raymond James
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Morgan Stanley
Gilead resumed with an Equal Weight at Morgan Stanley
10/29/20 BMO Capital
Gilead price target lowered to $64 from $74 at BMO Capital
RCUS Arcus Biosciences
$25.77 /

+1.365 (+5.59%)

GILD Gilead
$59.88 /

-0.22 (-0.37%)

  • 29
    May
GILD Gilead
$59.88 /

-0.22 (-0.37%)

RCUS Arcus Biosciences
$25.77 /

+1.365 (+5.59%)

GILD Gilead
$59.88 /

-0.22 (-0.37%)

GILD Gilead
$59.88 /

-0.22 (-0.37%)

Recommendations
Urban Outfitters price target raised to $37 from $26 at Barclays » 06:36
11/24/20
11/24
06:36
11/24/20
06:36
URBN

Urban Outfitters

$31.66 /

+1.335 (+4.40%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

11/23/20 Morgan Stanley
Urban Outfitters price target raised to $30 from $28 at Morgan Stanley
11/23/20 JPMorgan
Urban Outfitters price target raised to $27 from $19 at JPMorgan
11/18/20 B. Riley Securities
Urban Outfitters price target raised to $25 from $20 at B. Riley Securities
11/17/20
Fly Intel: Top five analyst downgrades
URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

URBN Urban Outfitters
$31.66 /

+1.335 (+4.40%)

Hot Stocks
Tiffany CEO says "We had terrific results in profitability' in Q3 » 06:36
11/24/20
11/24
06:36
11/24/20
06:36
TIF

Tiffany

$131.50 /

+0.07 (+0.05%)

Alessandro Bogliolo, CEO,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

10/28/20
LVMH, Tiffany near agreement on $131.50 per share price, WSJ reports
10/16/20 William Blair
Tiffany results strengthen legal standing against LVMH, says William Blair
09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

Downgrade
Silgan Holdings downgraded to Underperform from Neutral at BofA » 06:35
11/24/20
11/24
06:35
11/24/20
06:35
SLGN

Silgan Holdings

$34.53 /

+0.12 (+0.35%)

BofA analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$34.53 /

+0.12 (+0.35%)

SLGN Silgan Holdings
$34.53 /

+0.12 (+0.35%)

10/23/20 Seaport Global
Silgan Holdings upgraded to Buy from Neutral at Seaport Global
10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 BofA
Silgan Holdings downgraded to Neutral from Buy at BofA
10/22/20 BofA
Silgan Holdings downgraded to Neutral from Buy at BofA
SLGN Silgan Holdings
$34.53 /

+0.12 (+0.35%)

Downgrade
Amcor downgraded to Underperform from Neutral at BofA » 06:35
11/24/20
11/24
06:35
11/24/20
06:35
AMCR

Amcor

$11.57 /

-0.125 (-1.07%)

BofA analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMCR Amcor
$11.57 /

-0.125 (-1.07%)

10/14/20 Seaport Global
Amcor initiated with a Neutral at Seaport Global
08/21/20 Deutsche Bank
Amcor price target raised to $12 from $10 at Deutsche Bank
08/19/20 BMO Capital
Amcor price target raised to $11 from $9 at BMO Capital
07/08/20 BofA
Amcor initiated with a Neutral at BofA
AMCR Amcor
$11.57 /

-0.125 (-1.07%)

Upgrade
Domtar upgraded to Neutral from Underperform at BofA » 06:35
11/24/20
11/24
06:35
11/24/20
06:35
UFS

Domtar

$30.28 /

+1.37 (+4.74%)

BofA analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UFS Domtar
$30.28 /

+1.37 (+4.74%)

UFS Domtar
$30.28 /

+1.37 (+4.74%)

11/20/20 Citi
Citi calls Domtar 'most likely to be acquired' among Paper & Packaging names
11/09/20 Stephens
Domtar named a Best Idea at Stephens
09/25/20 Citi
Citi sees WestRock, Packaging Corp. matching IP's price hike shortly
08/14/20
Fly Intel: Top five analyst upgrades
UFS Domtar
$30.28 /

+1.37 (+4.74%)

UFS Domtar
$30.28 /

+1.37 (+4.74%)

Recommendations
Helmerich & Payne price target raised to $18 from $14 at Barclays » 06:35
11/24/20
11/24
06:35
11/24/20
06:35
HP

Helmerich & Payne

$23.06 /

+2.86 (+14.16%)

Barclays analyst J. David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HP Helmerich & Payne
$23.06 /

+2.86 (+14.16%)

11/23/20 RBC Capital
Helmerich & Payne price target raised to $23 from $20 at RBC Capital
11/23/20 Susquehanna
Helmerich & Payne price target raised to $25 from $18 at Susquehanna
10/13/20
Fly Intel: Top five analyst downgrades
10/13/20 BofA
Helmerich & Payne downgraded to Neutral on rig recovery pushout at BofA
HP Helmerich & Payne
$23.06 /

+2.86 (+14.16%)

HP Helmerich & Payne
$23.06 /

+2.86 (+14.16%)

HP Helmerich & Payne
$23.06 /

+2.86 (+14.16%)

HP Helmerich & Payne
$23.06 /

+2.86 (+14.16%)

Upgrade
O-I Glass upgraded to Buy from Neutral at BofA » 06:35
11/24/20
11/24
06:35
11/24/20
06:35
OI

O-I Glass

$11.85 /

+0.18 (+1.54%)

BofA analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OI O-I Glass
$11.85 /

+0.18 (+1.54%)

OI O-I Glass
$11.85 /

+0.18 (+1.54%)

10/14/20 Seaport Global
O-I Glass initiated with a Neutral at Seaport Global
08/06/20 Deutsche Bank
O-I Glass price target raised to $15 from $11 at Deutsche Bank
07/16/20 Baird
O-I Glass volume improved during June, says Baird
04/30/20 Barclays
O-I Glass price target lowered to $8 from $13 at Barclays
OI O-I Glass
$11.85 /

+0.18 (+1.54%)

OI O-I Glass
$11.85 /

+0.18 (+1.54%)

Hot Stocks
Tiffany reports net inventories at October 31 were 4% below the prior year  06:34
11/24/20
11/24
06:34
11/24/20
06:34
TIF

Tiffany

$131.50 /

+0.07 (+0.05%)

 
ShowHide Related Items >><<
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

10/28/20
LVMH, Tiffany near agreement on $131.50 per share price, WSJ reports
10/16/20 William Blair
Tiffany results strengthen legal standing against LVMH, says William Blair
09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

TIF Tiffany
$131.50 /

+0.07 (+0.05%)

Hot Stocks
MediciNova begins of GMP-based MVSS production of intranasal SARS-CoV-2 vaccine » 06:34
11/24/20
11/24
06:34
11/24/20
06:34
MNOV

MediciNova

$5.92 /

+0.03 (+0.51%)

MediciNova announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNOV MediciNova
$5.92 /

+0.03 (+0.51%)

MNOV MediciNova
$5.92 /

+0.03 (+0.51%)

MNOV MediciNova
$5.92 /

+0.03 (+0.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.